122 related articles for article (PubMed ID: 38262249)
1. Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer.
Young RJ; Angel C; Bressel M; Pizzolla A; Thai AA; Porceddu SV; Liu H; Idrizi R; Metta J; Lim AM; Solomon BJ; Rischin D
Oral Oncol; 2024 Mar; 150():106687. PubMed ID: 38262249
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
[TBL] [Abstract][Full Text] [Related]
5. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
6. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
7. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
Front Oncol; 2018; 8():589. PubMed ID: 30619735
[No Abstract] [Full Text] [Related]
8. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
[TBL] [Abstract][Full Text] [Related]
9. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
[TBL] [Abstract][Full Text] [Related]
10. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma.
Li Q; Liu X; Wang D; Wang Y; Lu H; Wen S; Fang J; Cheng B; Wang Z
Int J Oral Sci; 2020 Sep; 12(1):24. PubMed ID: 32934197
[TBL] [Abstract][Full Text] [Related]
12. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
[TBL] [Abstract][Full Text] [Related]
13. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
[TBL] [Abstract][Full Text] [Related]
14. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
15. Validation and characterisation of prognostically significant PD-L1
Young RJ; Bressel M; Porceddu S; Cernelc J; Savas P; Liu H; Urban D; Thai AA; Cooper C; Fua T; Neeson P; Rischin D; Solomon B
Oral Oncol; 2020 Feb; 101():104516. PubMed ID: 31838340
[TBL] [Abstract][Full Text] [Related]
16. Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
Yoo SH; Ock CY; Keam B; Park SJ; Kim TM; Kim JH; Jeon YK; Chung EJ; Kwon SK; Hah JH; Kwon TK; Jung KC; Kim DW; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2019 Nov; 34(6):1313-1323. PubMed ID: 30428646
[TBL] [Abstract][Full Text] [Related]
17. Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV
Li H; Zhu SW; Zhou JJ; Chen DR; Liu J; Wu ZZ; Wang WY; Zhang MJ; Sun ZJ
J Dent Res; 2023 Jun; 102(6):678-688. PubMed ID: 36883630
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
19. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
[TBL] [Abstract][Full Text] [Related]
20. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status.
Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH
BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
